Acticor Biotech SAS

    Acticor Biotech SAS

    EEURONEXT:ALACT
    0.25
    EUR
    0.00
    (0.00%)
    Acticor Biotech SAS
    EURONEXT:ALACT
    (Euronext)

    Recent

    price

    0.25

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2017
    2018
    2019
    2020
    2021
    2022
    2023
    EUR
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    - -
    -0.57
    -0.48
    -0.73
    -1.62
    -1.51
    -1.54
    Basic EPS, GAAP
    - -
    -0.52
    -0.41
    -0.64
    -1.77
    -1.15
    -1.08
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    -0.54
    -0.45
    -0.94
    -1.58
    -2.42
    -3.54
    Book Value per Share
    - -
    0.59
    0.79
    0.1
    1.32
    -0.28
    -0.44
    Tangible Book Value per Share
    - -
    11
    11
    11
    8
    11
    12
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    -11,662
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    1
    - -
    - -
    - -
    1
    Depreciation Expense
    - -
    -6
    -5
    -8
    -13
    -16
    -19
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    -11,978
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -3
    7
    9
    4
    13
    5
    - -
    Working Capital
    1
    1
    1
    2
    2
    7
    5
    LT Debt
    -4
    6
    9
    2
    11
    -2
    -5
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    104.48%
    136.87%
    Free Cash Flow
    - -
    26.82%
    7.67%
    Net Income, GAAP
    - -
    28.78%
    17.4%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    -1.62
    2022
    - -
    - -
    - -
    - -
    -1.51
    2023
    - -
    - -
    - -
    - -
    -1.54

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business